Showing results (1801-1810 of 9,136) with videos related to

Sort By:
Pageof 914
Cancer Medicine|July 4, 2024
Current evidence supporting associations of DNA methylation measurements with survivorship burdens in cancer survivors: A scoping reviewMichael Sayer, Ding Quan Ng, Raymond Chan, et al.
Cancer Medicine|June 28, 2024
NUP98-BPTF promotes oncogenic transformation through PIM1 upregulationMina Noura, Sakura Tomita, Takahiko Yasuda, et al.
Cancer Medicine|June 26, 2024
Impact of rural location on receipt of standard of care treatment and survival for locally advanced bladder cancer in LouisianaMegan Escott, Yong Yi, Ashley Foret, et al.
Cancer Medicine|June 26, 2024
Challenges and perspectives in use of artificial intelligence to support treatment recommendations in clinical oncologyGregor Duwe, Dominique Mercier, Crispin Wiesmann, et al.
Cancer Medicine|June 26, 2024
Development of a prediction model for suicidal ideation in patients with advanced cancer: A multicenter, real-world, pan-cancer study in ChinaYi He, Ying Pang, Wenlei Yang, et al.
Cancer Medicine|June 26, 2024
Prognostic analysis and outcomes of metastatic pancreatic cancer patients receiving nab-paclitaxel plus gemcitabine as second or later-line treatmentGuido Giordano, Michele Milella, Matteo Landriscina, et al.
Cancer Medicine|July 20, 2024
Comparison of treatment outcome between first-line combination immunotherapy (anti-PD-L1 or anti-PD1) with or without chemotherapy and chemotherapy alone in advanced non-small cell lung cancer patients in tertiary care hospitalDanainut Naratornsirakul, Busyamas Chewaskulyong, Sarawut Kongkarnka, et al.
Cancer Medicine|July 20, 2024
A propensity score-matched comparison of neoadjuvant chemoradiotherapy with cisplatin-5FU and carboplatin-paclitaxel in locally advanced esophageal squamous cell carcinoma: A Turkish oncology group studyFatih Gürler, Fatih Tay, Zehra Sucuoğlu İşleyen, et al.
Cancer Medicine|July 20, 2024
Real-world first-line treatment with pembrolizumab for non-small cell lung carcinoma with high PD-L1 expression: Updated analysisYasuyuki Ikezawa, Ryo Morita, Hidenori Mizugaki, et al.
Cancer Medicine|July 20, 2024
Cuproptosis-related gene DLAT is a biomarker of the prognosis and immune microenvironment of gastric cancer and affects the invasion and migration of cellsYanyu Peng, Ruimeng Shi, Siwen Yang, et al.
Pageof 914